Industry

WALTHAM, Mass. & CAMBRIDGE, England–(BUSINESS WIRE)–Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, announced that Young T. Kwon, PhD, Alchemab’s Chief Financial and Operating Officer, has succeeded Douglas A. Treco, PhD as Chief Executive Officer and member of the Board, who resigned … [Read more…]

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended March 31, 2022. Corporate and Clinical Development Highlights Include: Fortified Balance Sheet – On March 31, 2022, Can-Fite … [Read more…]

VirtaMed’s VR simulations provide advanced training for surgeons using MMI’s Symani® Robotic System and introduce new product testing capabilities ZURICH–(BUSINESS WIRE)–VirtaMed, a world leader in medical simulation training, and Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, have announced a partnership where surgeons using MMI’s Symani® Surgical … [Read more…]

BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participating in the upcoming William Blair 42nd Annual Growth Stock Conference. 908 Devices’ management is scheduled to present on Thursday, June 9th, at 8:00 a.m. Central Time / 9:00 … [Read more…]

The Company’s ProFoundry™ Platform has to date identified tens of thousands of previously undiscovered proteins that represent a vastly expanded number of therapeutic targets Flagship commits $75 million to enable the continued expansion of the ProFoundry™ Platform to support target discovery efforts and building of a robust R&D pipeline CAMBRIDGE, Mass.–(BUSINESS WIRE)–Flagship Pioneering, the bioplatform … [Read more…]

UNC School of Medicine researchers used MRI to document crucial differences in the visual processing system in the brains of infants who went on to be diagnosed with autism. CHAPEL HILL, N.C.–(BUSINESS WIRE)–For the first time, scientists have found that brain differences in the visual brain systems of infants who later are diagnosed with autism … [Read more…]

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #EHA2022–Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June 9-17; virtual and in Vienna). “We are committed to advancing science that can lead to solutions for patients with serious unmet medical needs, including those with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Anesthetics Global Market Report 2022, Type, Application, Route of Administration, Local Anesthetics, General Anesthetics” report has been added to ResearchAndMarkets.com’s offering. The global anesthetics market is expected to grow from $9.24 billion in 2021 to $9.88 billion in 2022 at a compound annual growth rate (CAGR) of 7.0 %. The market is expected … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Anesthesia And Respiratory Devices Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global anesthesia and respiratory devices market is expected to grow from $45.25 billion in 2021 to $51.51 billion in 2022 at a compound annual growth rate (CAGR) of 13.8%. The market is expected to grow to $82.25 … [Read more…]

Addition of Aalto Bio Reagents expands Biosynth Carbosynth’s offer to its clinical diagnostics customers. STAAD, Switzerland–(BUSINESS WIRE)–Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today the acquisition of Aalto Bio Reagents (“Aalto”), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry … [Read more…]